FDA inspection
SpineFrontier, Inc.: FDA inspection ending Apr 2, 2026
FDA inspection 1311082 · Voluntary Action Indicated (VAI) · Burlington, MA
Key facts
| Inspection ID | 1311082 |
|---|---|
| Firm | SpineFrontier, Inc. |
| FEI number | 3005977257 |
| Address | 200 Summit Dr Ste 505 |
| City | Burlington |
| State | MA |
| ZIP | 01803 |
| Country | United States |
| Fiscal year | 2026 |
| Inspection end date | Apr 2, 2026 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Postmarket Assurance: Devices |
| Product type | Devices |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data